Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1033 - 1040 of 12008 results
Bitcoin ETF Approval Doesn't Mean SEC Approves Of Crypto
February 13, 2024| News
Frequently Asked Questions for Private Companies Considering a Reverse Merger
February 13, 2024| Article| Viewpoint
EPA's Latest PFAS Action Leaves Unanswered Questions
February 13, 2024| News
EnforceMintz — Health Care Enforcement Trends & 2024 Outlook
February 12, 2024| Blog| Viewpoint
New Opportunities from DOE for Domestic Manufacturing of Advanced Batteries
February 12, 2024| News
Need Prior Art? Here’s How to Search the PTO Database of Patents Like a Patent Examiner
February 12, 2024| Blog| Viewpoint
Sports Gambling in the Workplace: A Safe Bet?
February 10, 2024| Blog| Viewpoint
EnforceMintz — DOJ’s Limited Use of NPAs and DPAs in Criminal Health Care Investigations
February 8, 2024| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|